Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds
US7034032B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2001 |
| Grant date | Apr 25, 2006 |
| Priority date | — |
| Expiry date | Nov 7, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel 1,2,3-triazolo[4,5-d]pyrimidine compounds, such as those represented by formula (I):their use as medicaments, particularly in platelet aggregation disorders, compositions containing them and processes for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.